Trial intelligence / Profile preview

Fimasartan and Atorvastatin Interaction Study

NCT02397590Phase 1Completed

Sponsor
Boryung
Start
Mar 2015
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of fimasartan and atorvastatin in hypertension (HTN) and hypercholesterolemia, sponsored by Boryung. Started Mar 2015; status: completed.

02

Drugs

fimasartanatorvastatin
03

Conditions

hypertension (HTN)hypercholesterolemia

Beyond the preview

Go deeper on NCT02397590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02397590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call